Table 2.
Comparison of HRV, EFT, and visfatin levels between the two groups
| Variables | The recurrence group (n = 235) | The non-recurrence group (n = 102) | t | P |
|---|---|---|---|---|
| HRV | ||||
| SDNN (ms) | 101.04 ± 14.29 | 100.01 ± 13.18 | 0.622 | 0.534 |
| rMSSD (ms) | 25.23 ± 2.12 | 21.76 ± 2.31 | 13.430 | < 0.001 |
| PNN50 (%) | 7.31 ± 1.23 | 4.67 ± 1.04 | 20.223 | < 0.001 |
| LF (ms2) | 128.93 ± 12.38 | 126.87 ± 11.29 | 1.440 | 0.151 |
| HF (ms2) | 256.23 ± 23.09 | 135.82 ± 22.13 | 44.530 | < 0.001 |
| LF/HF | 0.83 ± 0.23 | 1.19 ± 0.28 | − 11.420 | < 0.001 |
| Total EFT (cm3) | 103.29 ± 12.92 | 84.29 ± 11.29 | 13.356 | < 0.001 |
| Visfatin (g/ml) | 34.87 ± 3.21 | 23.23 ± 3.19 | 30.640 | < 0.001 |